Biomea Fusion Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	23.59	20.92	13.67	1.66	0.1
Research & Development	102.55	62.71	28	3.67	1.09
Operating Expenses	126.14	83.63	41.67	5.33	1.2
Operating Income	-126.14	-83.63	-41.67	-5.33	-1.2
Other Expense / Income	-8.88	-1.81	-0.1	-0	0
Pretax Income	-117.26	-81.83	-41.57	-5.32	-1.2
Net Income	-117.26	-81.83	-41.57	-5.32	-1.2
Shares Outstanding (Basic)	34	29	24	11	6
Shares Outstanding (Diluted)	34	29	24	11	6
Shares Change	16.52%	22.69%	126.51%	74.05%	-
EPS (Basic)	-3.44	-2.80	-1.74	-0.51	-0.20
EPS (Diluted)	-3.44	-2.80	-1.74	-0.51	-0.20
Free Cash Flow	-99.96	-63.45	-38.61	-4.51	-1.28
Free Cash Flow Per Share	-2.93	-2.17	-1.62	-0.43	-0.21
EBITDA	-113.05	-80.57	-40.61	-5.19	-1.2
Depreciation & Amortization	4.2	1.26	0.95	0.13	0
EBIT	-117.26	-81.83	-41.57	-5.32	-1.2

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).